NCT02116010View on ClinicalTrials.gov

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients

PHASE1/PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2016

Conditions
Wound Infection
Interventions
DRUG

E. coli Phages cocktail

Use of Pherecydes Pharma Phages cocktail to treat respectively E. coli burn wound infection

DRUG

Standard of care : Silver Sulfadiazine

Use of Standard of care : Silver Sulfadiazine, to treat E. coli or P. aeruginosa infected burn wound

DRUG

P. Aeruginosa, Phages cocktail

Use of Pherecydes Pharma Phages cocktail to treat P. aeruginosa burn wound infection

Trial Locations (5)

92141

RECRUITING

Hôpital d'instruction des armées Percy, Clamart

B-1120

NOT_YET_RECRUITING

Hopital Militaire Reine Astrid, Brussels

Unknown

NOT_YET_RECRUITING

CHU Sart-Tilman, Liège

F-69365

NOT_YET_RECRUITING

Centre hospitalier ST Joseph et St Luc, Lyon

CH-1011

NOT_YET_RECRUITING

Centre Hospitalier Universitaire Vaudois, Lausanne

Sponsors
All Listed Sponsors
lead

Phaxiam Therapeutics

INDUSTRY

NCT02116010 - Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients | Biotech Hunter | Biotech Hunter